These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 4074434

  • 1. Hemodynamic effect of cilostazol on increasing peripheral blood flow in arteriosclerosis obliterans.
    Yasuda K, Sakuma M, Tanabe T.
    Arzneimittelforschung; 1985; 35(7A):1198-200. PubMed ID: 4074434
    [Abstract] [Full Text] [Related]

  • 2. Hemodynamic effects of the antithrombotic drug cilostazol in chronic arterial occlusion in the extremities.
    Kamiya T, Sakaguchi S.
    Arzneimittelforschung; 1985; 35(7A):1201-3. PubMed ID: 4074435
    [Abstract] [Full Text] [Related]

  • 3. Thermographic evaluation of the hemodynamic effect of the antithrombotic drug cilostazol in peripheral arterial occlusion.
    Ohashi S, Iwatani M, Hyakuna Y, Morioka Y.
    Arzneimittelforschung; 1985; 35(7A):1203-8. PubMed ID: 4074436
    [Abstract] [Full Text] [Related]

  • 4. General pharmacological properties of cilostazol, a new antithrombotic drug. Part II: Effect on the peripheral organs.
    Shintani S, Watanabe K, Kawamura K, Mori T, Tani T, Toba Y, Sasabe H, Nakagiri N, Hongoh O, Fujita S.
    Arzneimittelforschung; 1985; 35(7A):1163-72. PubMed ID: 3000392
    [Abstract] [Full Text] [Related]

  • 5. Effect of cilostazol, a new antithrombotic drug, on cerebral circulation.
    Kawamura K, Watanabe K, Kimura Y.
    Arzneimittelforschung; 1985; 35(7A):1149-54. PubMed ID: 4074427
    [Abstract] [Full Text] [Related]

  • 6. Long-term effect of cilostazol on cerebral blood flow in chronic cerebral infarction.
    Kobayashi S, Yamaguchi S, Katsube T, Kitani M, Okada K, Tsunematsu T.
    Arzneimittelforschung; 1985; 35(7A):1193-7. PubMed ID: 4074433
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. General pharmacological properties of cilostazol, a new antithrombotic drug. Part I: Effects on the central nervous system.
    Shintani S, Toba Y, Suzuki S, Ninomiya S, Umezato M, Hiyama T.
    Arzneimittelforschung; 1985; 35(7A):1157-62. PubMed ID: 4074429
    [Abstract] [Full Text] [Related]

  • 11. Effect of cilostazol, a new antithrombotic drug, on an experimental model of peripheral circulation insufficiency.
    Kawamura K, Fujita S, Tani T, Kimura Y.
    Arzneimittelforschung; 1985; 35(7A):1154-6. PubMed ID: 4074428
    [Abstract] [Full Text] [Related]

  • 12. Physico-chemical properties and stability of cilostazol.
    Shimizu T, Osumi T, Niimi K, Nakagawa K.
    Arzneimittelforschung; 1985; 35(7A):1117-23. PubMed ID: 4074422
    [Abstract] [Full Text] [Related]

  • 13. Hemodynamic effects of cilostazol on peripheral artery in patients with diabetic neuropathy.
    Okuda Y, Mizutani M, Ikegami T, Ueno E, Yamashita K.
    Arzneimittelforschung; 1992 Apr; 42(4):540-2. PubMed ID: 1642679
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of cilostazol with warfarin as antithrombotic therapy after femoro-popliteal bypass surgery using an ePTFE graft.
    Ohtake H, Urayama H, Kimura K, Yokoi K, Tsunezuka Y, Kawakami T, Kawasuji M, Watanabe Y.
    Minerva Cardioangiol; 1997 Nov; 45(11):527-30. PubMed ID: 9549283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.